Phillip Anderson, Head of Policy at the MS Society UK, describes the need to improve multiple sclerosis treatment, care & support, including access to disease modifying therapies.
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
British Skin Foundation walk us through the two main types of skin cancer, melanoma & non-melanoma, and the importance of funding research in the field.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, lifts the lid on predictive toxicology evolving from in vivo to in vitro to in silico systems starting with a look at organoids & organ-on-chip microfluidic devices.
Dr Vijay Magon, Managing Director of CCube Solutions, demonstrates here how their project successes and expertise working with the NHS is providing cost-effective and scalable solutions, tailored to meet individual requirements.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, argues that toxicological research is key to sustaining human health and wellbeing
.
Some of the world's most poisonous mushrooms can be spotted in the UK from the end of summer onwards - here's what to look out for on your next autumnal walk.
Mark Hitchman, Managing Director of Canon Medical Systems UK, explains why AI in healthcare can deliver time efficiencies & better standards of care for patients.
